연구동향 분석

Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB

이승헌 김동현 서경아 이영민 이현경 김제형 신철 김종률 신재국 2015년

논문상세정보
인용/피인용
' Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • cycloserine
  • drug monitoring
  • moxifloxacin
  • multidrug resistance
  • prothionamide
  • tuberculosis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,010 0

0.0%

' Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB' 의 참고문헌

  • Vargas-Vasquez DE, et al. Delamanid for multidrug-resistant pulmonary tuberculosis
    Gler MT N Engl J Med 366 : 2151 ~ 2160 [2012]
  • Vargas-Vasquez DE, et al. Delamanid for multidrug-resistant pulmonary tuberculosis
    Gler MT N Engl J Med 366 2151-2160 [2012]
  • Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patients
    Li J Chest 126 : 1770 ~ 1776 [2004]
  • Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patients
    Li J Chest 126 1770-1776 [2004]
  • Trend of anti-tuberculosis drug resistance in Korea, 1994-2004
    Bai GH Int J Tuberc Lung Dis 11 : 571 ~ 576 [2007]
  • Trend of anti-tuberculosis drug resistance in Korea, 1994-2004
    Bai GH Int J Tuberc Lung Dis 11 571-576 [2007]
  • Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis
    Kim DH Am J Respir Crit Care Med 182 : 113 ~ 119 [2010]
  • Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis
    Kim DH Am J Respir Crit Care Med 182 113-119 [2010]
  • Therapeutic drug monitoring in the treatment of tuberculosis
    Peloquin CA Drugs 62 : 2169 ~ 2183 [2002]
  • Therapeutic drug monitoring in the treatment of tuberculosis
    Peloquin CA Drugs 62 2169-2183 [2002]
  • The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis
    Weis SE N Engl J Med 330 : 1179 ~ 1184 [1994]
  • The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis
    Weis SE N Engl J Med 330 1179-1184 [1994]
  • Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana
    Tappero JW Clin Infect Dis 41 : 461 ~ 469 [2005]
  • Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana
    Tappero JW Clin Infect Dis 41 461-469 [2005]
  • Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis
    Alffenaar JW Clin Infect Dis 49 : 1080 ~ 1082 [2009]
  • Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis
    Alffenaar JW Clin Infect Dis 49 1080-1082 [2009]
  • Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model
    Wallis RS PLoS One 8 : e71116 ~ [2013]
  • Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model
    Wallis RS PLoS One 8 e71116- [2013]
  • Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy
    Pasipanodya JG Clin Infect Dis 55 : 169 ~ 177 [2012]
  • Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy
    Pasipanodya JG Clin Infect Dis 55 169-177 [2012]
  • Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients
    Kimerling ME Chest 113 : 1178 ~ 1183 [1998]
  • Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients
    Kimerling ME Chest 113 1178-1183 [1998]
  • Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia
    van Crevel R Int J Tuberc Lung Dis 6 : 497 ~ 502 [2002]
  • Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia
    van Crevel R Int J Tuberc Lung Dis 6 497-502 [2002]
  • Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis
    Kim HR Clin Infect Dis 45 : 1290 ~ 1295 [2007]
  • Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis
    Kim HR Clin Infect Dis 45 1290-1295 [2007]
  • Guidelines for the programmatic management of drug-resistant tuberculosis-2011 update
    World Health Organization World Health Organization [2011]
  • Global tuberculosis control: WHO report 2011
  • Global tuberculosis control: WHO report 2011
  • Economic and outcome issues for therapeutic drug monitoring in medicine
    Schumacher GE Ther Drug Monit 20 : 539 ~ 542 [1998]
  • Economic and outcome issues for therapeutic drug monitoring in medicine
    Schumacher GE Ther Drug Monit 20 539-542 [1998]
  • Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA
    Heysell SK Tuberc Res Treat 2013 : 129723 ~ [2013]
  • Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA
    Heysell SK Tuberc Res Treat 2013 129723- [2013]
  • Diagnostic standards and classification of tuberculosis
    U.S. National Tuberculosis Association National Tuberculosis Association [1961]
  • Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients
    McIlleron H Antimicrob Agents Chemother 50 : 1170 ~ 1177 [2006]
  • Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients
    McIlleron H Antimicrob Agents Chemother 50 1170-1177 [2006]
  • Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model
    Cremades R J Antimicrob Chemother 66 : 2281 ~ 2283 [2011]
  • Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model
    Cremades R J Antimicrob Chemother 66 2281-2283 [2011]
  • Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis
    Koh WJ Am J Respir Crit Care Med 188 : 858 ~ 864 [2013]
  • Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis
    Koh WJ Am J Respir Crit Care Med 188 858-864 [2013]
  • Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis
    Weiner M Clin Infect Dis 40 : 1481 ~ 1491 [2005]
  • Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis
    Weiner M Clin Infect Dis 40 1481-1491 [2005]
  • American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America : treatment of tuberculosis
    Blumberg HM Am J Respir Crit Care Med 167 : 603 ~ 662 [2003]
  • American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America : treatment of tuberculosis
    Blumberg HM Am J Respir Crit Care Med 167 603-662 [2003]